Marapharm Ventures (CSE:MDM) announced a fully funded operating agreement with Full Spectrum Medicinal and provided an update on its medical license application.

As quoted in the press release:


Marapharm has taken immediate action to amend two items on its late- stage Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) application. The Company is currently amending the location for its license application to Celista, BC, FSM’s 40-acre site, 1 hour from Salmon Arm and the new appointment of a Quality Assurance Person (QAP).

10 – 10,000 sq. ft. engineered bio-secure facilities, which have been fully funded by FSM, will be constructed in two phases, ultimately maximizing the potential of our 100,000 [square feet] ACMPR licence once approved by Health Canada. Ground preparation on the site began on August 15.

As a Canadian based company, we are confident about the demand and anticipated size of the Canadian cannabis market. This strategic alliance is mutually beneficial and will bring great shareholder value.” Linda Sampson, CEO.

Click here to read the full press release.

Source: www.newswire.ca

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less